tiprankstipranks
Cardiol Therapeutics (CRDL)
NASDAQ:CRDL
US Market
CRDL
Cardiol Therapeutics
RESEARCH TOOLSreports
Want to see CRDL full AI Analyst Report?

Cardiol Therapeutics (CRDL) Financial Statements

618 Followers

Cardiol Therapeutics Financial Overview

Cardiol Therapeutics's market cap is currently $158.94M. The company's EPS TTM is $-0.05108817; its P/E ratio is -3.37; Cardiol Therapeutics is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 78.76K
Gross ProfitC$ 0.00C$ -373.11KC$ -248.35KC$ -219.91KC$ 78.76K
Operating IncomeC$ -34.32MC$ -40.28MC$ -29.79MC$ -50.34MC$ -45.47M
EBITDAC$ -34.21MC$ -36.30MC$ -27.88MC$ -30.71MC$ -38.44M
Net IncomeC$ -33.82MC$ -36.68MC$ -28.13MC$ -11.52MC$ -24.72M
Balance Sheet
Cash & Short-Term InvestmentsC$ 21.42MC$ 30.58MC$ 34.93MC$ 59.47MC$ 83.90M
Total AssetsC$ 23.62MC$ 31.86MC$ 36.70MC$ 62.03MC$ 87.88M
Total DebtC$ 125.52KC$ 158.53KC$ 158.53KC$ 72.87KC$ 117.58K
Net DebtC$ -21.29MC$ -30.42MC$ -34.77MC$ -59.40MC$ -83.78M
Total LiabilitiesC$ 5.74MC$ 7.14MC$ 8.45MC$ 9.83MC$ 11.64M
Stockholders' EquityC$ 17.88MC$ 24.73MC$ 28.25MC$ 52.20MC$ 76.24M
Cash Flow
Free Cash FlowC$ -23.88MC$ -25.08MC$ -25.25KC$ -27.30MC$ -23.56M
Operating Cash FlowC$ -23.85MC$ -25.06MC$ -25.18KC$ -27.22MC$ -23.55M
Investing Cash FlowC$ -24.48KC$ -21.29KC$ -64.31KC$ -74.71KC$ -12.92K
Financing Cash FlowC$ 15.54MC$ 18.84MC$ -55.38KC$ -53.93KC$ 93.44M
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

Income Statement >

Cardiol Therapeutics Debt to Assets

Balance Sheet >

Cardiol Therapeutics Cash Flow

Cash Flow >

Cardiol Therapeutics Forecast EPS vs Actual EPS

Earnings >